BryTan
2021-04-28
Interesting portfolio
4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization<blockquote>4家加拿大大麻公司准备从美国合法化中获利</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":377715517,"tweetId":"377715517","gmtCreate":1619565496739,"gmtModify":1634211821956,"author":{"id":3582656654028726,"idStr":"3582656654028726","authorId":3582656654028726,"authorIdStr":"3582656654028726","name":"BryTan","avatar":"https://static.tigerbbs.com/16c10be2f081c8f11ec0fe39f875fe9b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Interesting portfolio</p></body></html>","htmlText":"<html><head></head><body><p>Interesting portfolio</p></body></html>","text":"Interesting portfolio","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/377715517","repostId":1194611822,"repostType":4,"repost":{"id":"1194611822","kind":"news","pubTimestamp":1619532498,"share":"https://www.laohu8.com/m/news/1194611822?lang=zh_CN&edition=full","pubTime":"2021-04-27 22:08","market":"us","language":"en","title":"4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization<blockquote>4家加拿大大麻公司准备从美国合法化中获利</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194611822","media":"Motley Fool","summary":"As more and more states legalize marjiuana, federal legalization in the U.S. seems inevitable. Not o","content":"<p>As more and more states legalize marjiuana, federal legalization in the U.S. seems inevitable. Not only are more states passing legislation to permit recreational use, but a vast majority of Americans also support legalization. According to a recent survey, Pew Research found that 91% of people in the U.S. believe marijuana should be legal for either medical or recreational use, with 60% in favor of both. President Joe Biden is in favor of decriminalizing marijuana, while Senate Majority Leader Chuck Schumer is ready to push ahead with full legalization efforts even if Biden isn't completely on board just yet.</p><p><blockquote>随着越来越多的州将marjiuana合法化,美国的联邦合法化似乎是不可避免的。不仅越来越多的州通过立法允许娱乐用途,而且绝大多数美国人也支持合法化。根据最近的一项调查,皮尤研究中心发现,91%的美国人认为大麻用于医疗或娱乐用途应该是合法的,60%的人赞成两者兼而有之。总统乔·拜登支持大麻合法化,而参议院多数党领袖查克·舒默准备推进全面合法化的努力,即使拜登还没有完全同意。</blockquote></p><p>When legalization happens, there are many Canadian cannabis producers that will be ready to expand their presence south of the border.<b>Canopy Growth</b>(NASDAQ:CGC), soon-to-be-joined<b>Aphria</b>(NASDAQ:APHA)and<b>Tilray</b>(NASDAQ:TLRY), <b>Cronos</b>(NASDAQ:CRON), and <b>Aurora Cannabis</b>(NYSE:ACB)could be some of the biggest winners if (or, when) the U.S. pot market opens up.</p><p><blockquote>当合法化发生时,许多加拿大大麻生产商将准备扩大他们在边境以南的存在。<b>冠层生长</b>(纳斯达克:CGC),即将加入<b>Aphria</b>(纳斯达克:APHA)及<b>蒂尔雷</b>(纳斯达克:TLRY),<b>克罗诺斯</b>(纳斯达克:CRON),以及<b>奥罗拉大麻</b>如果(或当)美国大麻市场开放,(纽约证券交易所股票代码:ACB)可能会成为最大的赢家之一。</blockquote></p><p><img src=\"https://static.tigerbbs.com/31372c5518facc6093b15a7ca40146a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源:盖蒂图片社。</blockquote></p><p>1. Canopy Growth</p><p><blockquote>1.冠层生长</blockquote></p><p>Canopy Growth has partnerships set up so that it can start working on expansion almost immediately after legalization takes place. One of the first things it would be able to do is close on its acquisition of<b>Acreage Holdings</b>. Although the two companies came to an agreement in 2019, the transaction is still pending. The multistate operator has a footprint in 13 states with 29 dispensaries that are up and running. In 2020, it reported sales of $114.5 million, which rose 55% year over year. With Acreage Holdings, Canopy Growth would be ready to rival big names like<b>Curaleaf</b>and <b>Trulieve</b>right off the bat.</p><p><blockquote>Canopy Growth已经建立了合作伙伴关系,以便在合法化后几乎可以立即开始扩张。它能做的第一件事就是即将收购<b>面积控股</b>.尽管两家公司在2019年达成了协议,但交易仍悬而未决。这家多州运营商在13个州拥有29家药房。2020年,其销售额为1.145亿美元,同比增长55%。凭借种植面积,Canopy Growth将准备好与诸如<b>库拉利夫</b>和<b>Trulieve</b>马上。</blockquote></p><p>Plus, the company is also working with investor<b>ConstellationBrands</b>, which owns nearly 40% of the business, to develop cannabis beverages. Tapping into Constellation's distribution network, Canopy Growth will be poised to grab even more potential market share right out of the gate. And that is why thismarijuana stockis at the top of this list -- it is easily the best positioned cannabis company in Canada to benefit from U.S. legalization.</p><p><blockquote>此外,该公司还与投资者合作<b>星座品牌</b>拥有该业务近40%的股份,开发大麻饮料。利用Constellation的分销网络,Canopy Growth将立即抢占更多潜在市场份额。这就是为什么ThisMarijuana Stocky位居榜首——它无疑是加拿大最有能力从美国合法化中受益的大麻公司。</blockquote></p><p>2. Aphria and Tilray</p><p><blockquote>2.Aphria和Tilray</blockquote></p><p>Themerger between Aphria and Tilrayputs these two companies next on this list as together, they will have the next-best opportunities in the U.S. In November, Aphria announced the acquisition of SweetWater Brewing. And although the craft brewer does have the 420 brand, which suggests that it makes cannabis drinks, it actually uses hemp (which is legal in the U.S.) to<i>emulate</i>popular cannabis strains. Legalization would pave the way for the real deal. Tilray has partnered with<b>Anheuser-Busch Inbev</b>since 2018 on developing drinks for the Canadian pot market, and it will also have beverages that are ready to go.</p><p><blockquote>Aphria和Tilray之间的合并使这两家公司成为这份名单的下一个,因为它们共同将在美国拥有下一个最好的机会。11月,Aphria宣布收购SweetWater Brewing。尽管这家精酿啤酒制造商确实拥有420品牌,这表明它生产大麻饮料,但它实际上使用大麻(在美国是合法的)来<i>仿效</i>流行的大麻品种。合法化将为真正的交易铺平道路。Tilray与<b>百威英博</b>自2018年开始为加拿大大麻市场开发饮料,它也将有现成的饮料。</blockquote></p><p>Tilray has also been building out its position in other ways. Hemp plays a big part in its business, generating more than one-third of its revenue in 2020. In 2019, Tilray acquired Manitoba Harvest, a leading hemp business with products that are sold in thousands of retailers across the U.S. and Canada. Through its hemp operations, Tilray can leverage the existing relationships it has with retailers to potentially sell other cannabis products to them post-legalization.</p><p><blockquote>Tilray还通过其他方式巩固了自己的地位。大麻在其业务中发挥着重要作用,2020年占其收入的三分之一以上。2019年,Tilray收购了Manitoba Harvest,这是一家领先的大麻企业,其产品在美国和加拿大的数千家零售商处销售。通过其大麻业务,Tilray可以利用其与零售商的现有关系,在合法化后向他们销售其他大麻产品。</blockquote></p><p>3. Cronos</p><p><blockquote>3.克罗诺斯</blockquote></p><p>Cronos acquired cannabidiol (CBD) brand Lord Jones in 2019 from Redwood Holding Group. The company sells a variety of CBD-infused products, including oils and gummies. Last year, sales from the U.S. totaled $9.5 million and accounted for just 20% of its consolidated net revenue. But Cronos is definitely looking to change that. Earlier this year it partnered with actress Kristen Bell to launch a series of CBD products under its Happy Dance brand, which will be available at more than 550<b>Ulta Beauty</b>locations.</p><p><blockquote>Cronos于2019年从红杉控股集团收购了大麻二酚(CBD)品牌Lord Jones。该公司销售各种CBD产品,包括油和橡皮糖。去年,来自美国的销售额总计950万美元,仅占其合并净收入的20%。但是克罗诺斯肯定想改变这一点。今年早些时候,它与女演员基丝汀·贝尔合作,推出了旗下Happy Dance品牌的一系列CBD产品,售价超过550英镑<b>Ulta美容</b>地点。</blockquote></p><p>Like Canopy Growth, Cronos also benefits from having a partner that can accelerate its growth in the U.S. Tobacco giant<b>Altria</b>invested $1.8 billion into the cannabis company in 2018. With deep pockets and wide reach across the states, Altria can help Cronos break into more markets after legalization.</p><p><blockquote>与Canopy Growth一样,Cronos也受益于拥有一个可以加速其在美国烟草巨头增长的合作伙伴<b>奥驰亚</b>2018年向这家大麻公司投资了18亿美元。凭借雄厚的财力和在各州的广泛影响力,奥驰亚可以在合法化后帮助Cronos打入更多市场。</blockquote></p><p>4. Aurora Cannabis</p><p><blockquote>4.极光大麻</blockquote></p><p>Aurora doesn't have a big partner it can lean on, but the company has been making moves to take advantage of opportunities in the U.S. In May 2020, it announced entry into the U.S. market through the acquisition of Reliva, which makes CBD products. The acquisition also brought on board CEO Miguel Martin, who was previously at the helm of Reliva and has 25 years of experience in consumer packaged goods. Reliva's products are in more than 20,000 retail locations and at the time of the acquisition, it claimed to be the \"only CBD company in the three largest U.S. wholesale distributors.\"</p><p><blockquote>Aurora没有可以依靠的大合作伙伴,但该公司一直在采取措施利用美国的机遇。2020年5月,它宣布通过收购生产CBD产品的Reliva进入美国市场。此次收购还聘请了首席执行官米格尔·马丁(Miguel Martin),他曾执掌Reliva,在消费品领域拥有25年的经验。Reliva的产品遍布20,000多个零售点,在收购时,它声称自己是“美国三大批发分销商中唯一的CBD公司”。</blockquote></p><p></p><p>Although Aurora doesn't specifically break out U.S.-related sales, it is safe to assume this transaction, which cost the company approximately $40 million worth of shares (potentially up to $45 million), isn't going to put the company into as promising a position as the other pot stocks on this list. Aurora closed on the transaction in May 2020, but even when including Reliva's results into its operations, it has struggled to generate meaningful growth. In its second-quarter earnings report, released on Feb. 11, its net revenue of 67.7 million Canadian dollars for the period ending Dec. 31, 2020 was flat from the previous period.</p><p><blockquote>尽管Aurora没有具体公布与美国相关的销售情况,但可以肯定的是,这笔交易使该公司损失了价值约4000万美元(可能高达4500万美元)的股票,不会让该公司陷入与该名单上的其他大麻股一样有前途的地位。Aurora于2020年5月完成了交易,但即使将Reliva的业绩纳入其运营中,它也难以实现有意义的增长。在2月11日发布的第二季度收益报告中,截至2020年12月31日的净收入为6770万加元,与上一期持平。</blockquote></p><p>However, investors shouldn't count the company out. Once pot is legal in the U.S., that may open the door for other potential deals for Aurora. Although billionaire investor Nelson Peltz was unable to broker a transaction, more opportunities could arise once the prohibition of marijuana is over and it no longer deters companies in other industries from jumping into the cannabis sector.</p><p><blockquote>然而,投资者不应将该公司排除在外。一旦大麻在美国合法化,这可能会为Aurora的其他潜在交易打开大门。尽管亿万富翁投资者纳尔逊·佩尔茨(Nelson Peltz)无法促成交易,但一旦大麻禁令结束并且不再阻止其他行业的公司进入大麻行业,可能会出现更多机会。</blockquote></p><p>Here's The Marijuana Stock You've Been Waiting For</p><p><blockquote>这是您一直在等待的大麻库存</blockquote></p><p>A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.</p><p><blockquote>一家鲜为人知的加拿大公司刚刚解锁了一些专家认为可能是从即将到来的大麻热潮中获利的关键。</blockquote></p><p>And make no mistake – it is coming.</p><p><blockquote>毫无疑问,它即将到来。</blockquote></p><p>Cannabis legalization is sweeping over North America – 16 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.</p><p><blockquote>大麻合法化正在席卷北美——过去几年,16个州加上华盛顿特区都将娱乐性大麻合法化,加拿大于2018年10月实现了全面合法化。</blockquote></p><p>And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.</p><p><blockquote>一家不为人知的加拿大公司正准备在即将到来的大麻革命中爆发。</blockquote></p><p>Because a game-changing deal just went down between the Ontario government and this powerhouse company...and you need to hear this story today if you have even considered investing in pot stocks.</p><p><blockquote>因为安大略省政府和这家强大的公司刚刚达成了一项改变游戏规则的协议……如果您甚至考虑过投资大麻股票,您今天就需要听听这个故事。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization<blockquote>4家加拿大大麻公司准备从美国合法化中获利</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization<blockquote>4家加拿大大麻公司准备从美国合法化中获利</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-04-27 22:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>As more and more states legalize marjiuana, federal legalization in the U.S. seems inevitable. Not only are more states passing legislation to permit recreational use, but a vast majority of Americans also support legalization. According to a recent survey, Pew Research found that 91% of people in the U.S. believe marijuana should be legal for either medical or recreational use, with 60% in favor of both. President Joe Biden is in favor of decriminalizing marijuana, while Senate Majority Leader Chuck Schumer is ready to push ahead with full legalization efforts even if Biden isn't completely on board just yet.</p><p><blockquote>随着越来越多的州将marjiuana合法化,美国的联邦合法化似乎是不可避免的。不仅越来越多的州通过立法允许娱乐用途,而且绝大多数美国人也支持合法化。根据最近的一项调查,皮尤研究中心发现,91%的美国人认为大麻用于医疗或娱乐用途应该是合法的,60%的人赞成两者兼而有之。总统乔·拜登支持大麻合法化,而参议院多数党领袖查克·舒默准备推进全面合法化的努力,即使拜登还没有完全同意。</blockquote></p><p>When legalization happens, there are many Canadian cannabis producers that will be ready to expand their presence south of the border.<b>Canopy Growth</b>(NASDAQ:CGC), soon-to-be-joined<b>Aphria</b>(NASDAQ:APHA)and<b>Tilray</b>(NASDAQ:TLRY), <b>Cronos</b>(NASDAQ:CRON), and <b>Aurora Cannabis</b>(NYSE:ACB)could be some of the biggest winners if (or, when) the U.S. pot market opens up.</p><p><blockquote>当合法化发生时,许多加拿大大麻生产商将准备扩大他们在边境以南的存在。<b>冠层生长</b>(纳斯达克:CGC),即将加入<b>Aphria</b>(纳斯达克:APHA)及<b>蒂尔雷</b>(纳斯达克:TLRY),<b>克罗诺斯</b>(纳斯达克:CRON),以及<b>奥罗拉大麻</b>如果(或当)美国大麻市场开放,(纽约证券交易所股票代码:ACB)可能会成为最大的赢家之一。</blockquote></p><p><img src=\"https://static.tigerbbs.com/31372c5518facc6093b15a7ca40146a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源:盖蒂图片社。</blockquote></p><p>1. Canopy Growth</p><p><blockquote>1.冠层生长</blockquote></p><p>Canopy Growth has partnerships set up so that it can start working on expansion almost immediately after legalization takes place. One of the first things it would be able to do is close on its acquisition of<b>Acreage Holdings</b>. Although the two companies came to an agreement in 2019, the transaction is still pending. The multistate operator has a footprint in 13 states with 29 dispensaries that are up and running. In 2020, it reported sales of $114.5 million, which rose 55% year over year. With Acreage Holdings, Canopy Growth would be ready to rival big names like<b>Curaleaf</b>and <b>Trulieve</b>right off the bat.</p><p><blockquote>Canopy Growth已经建立了合作伙伴关系,以便在合法化后几乎可以立即开始扩张。它能做的第一件事就是即将收购<b>面积控股</b>.尽管两家公司在2019年达成了协议,但交易仍悬而未决。这家多州运营商在13个州拥有29家药房。2020年,其销售额为1.145亿美元,同比增长55%。凭借种植面积,Canopy Growth将准备好与诸如<b>库拉利夫</b>和<b>Trulieve</b>马上。</blockquote></p><p>Plus, the company is also working with investor<b>ConstellationBrands</b>, which owns nearly 40% of the business, to develop cannabis beverages. Tapping into Constellation's distribution network, Canopy Growth will be poised to grab even more potential market share right out of the gate. And that is why thismarijuana stockis at the top of this list -- it is easily the best positioned cannabis company in Canada to benefit from U.S. legalization.</p><p><blockquote>此外,该公司还与投资者合作<b>星座品牌</b>拥有该业务近40%的股份,开发大麻饮料。利用Constellation的分销网络,Canopy Growth将立即抢占更多潜在市场份额。这就是为什么ThisMarijuana Stocky位居榜首——它无疑是加拿大最有能力从美国合法化中受益的大麻公司。</blockquote></p><p>2. Aphria and Tilray</p><p><blockquote>2.Aphria和Tilray</blockquote></p><p>Themerger between Aphria and Tilrayputs these two companies next on this list as together, they will have the next-best opportunities in the U.S. In November, Aphria announced the acquisition of SweetWater Brewing. And although the craft brewer does have the 420 brand, which suggests that it makes cannabis drinks, it actually uses hemp (which is legal in the U.S.) to<i>emulate</i>popular cannabis strains. Legalization would pave the way for the real deal. Tilray has partnered with<b>Anheuser-Busch Inbev</b>since 2018 on developing drinks for the Canadian pot market, and it will also have beverages that are ready to go.</p><p><blockquote>Aphria和Tilray之间的合并使这两家公司成为这份名单的下一个,因为它们共同将在美国拥有下一个最好的机会。11月,Aphria宣布收购SweetWater Brewing。尽管这家精酿啤酒制造商确实拥有420品牌,这表明它生产大麻饮料,但它实际上使用大麻(在美国是合法的)来<i>仿效</i>流行的大麻品种。合法化将为真正的交易铺平道路。Tilray与<b>百威英博</b>自2018年开始为加拿大大麻市场开发饮料,它也将有现成的饮料。</blockquote></p><p>Tilray has also been building out its position in other ways. Hemp plays a big part in its business, generating more than one-third of its revenue in 2020. In 2019, Tilray acquired Manitoba Harvest, a leading hemp business with products that are sold in thousands of retailers across the U.S. and Canada. Through its hemp operations, Tilray can leverage the existing relationships it has with retailers to potentially sell other cannabis products to them post-legalization.</p><p><blockquote>Tilray还通过其他方式巩固了自己的地位。大麻在其业务中发挥着重要作用,2020年占其收入的三分之一以上。2019年,Tilray收购了Manitoba Harvest,这是一家领先的大麻企业,其产品在美国和加拿大的数千家零售商处销售。通过其大麻业务,Tilray可以利用其与零售商的现有关系,在合法化后向他们销售其他大麻产品。</blockquote></p><p>3. Cronos</p><p><blockquote>3.克罗诺斯</blockquote></p><p>Cronos acquired cannabidiol (CBD) brand Lord Jones in 2019 from Redwood Holding Group. The company sells a variety of CBD-infused products, including oils and gummies. Last year, sales from the U.S. totaled $9.5 million and accounted for just 20% of its consolidated net revenue. But Cronos is definitely looking to change that. Earlier this year it partnered with actress Kristen Bell to launch a series of CBD products under its Happy Dance brand, which will be available at more than 550<b>Ulta Beauty</b>locations.</p><p><blockquote>Cronos于2019年从红杉控股集团收购了大麻二酚(CBD)品牌Lord Jones。该公司销售各种CBD产品,包括油和橡皮糖。去年,来自美国的销售额总计950万美元,仅占其合并净收入的20%。但是克罗诺斯肯定想改变这一点。今年早些时候,它与女演员基丝汀·贝尔合作,推出了旗下Happy Dance品牌的一系列CBD产品,售价超过550英镑<b>Ulta美容</b>地点。</blockquote></p><p>Like Canopy Growth, Cronos also benefits from having a partner that can accelerate its growth in the U.S. Tobacco giant<b>Altria</b>invested $1.8 billion into the cannabis company in 2018. With deep pockets and wide reach across the states, Altria can help Cronos break into more markets after legalization.</p><p><blockquote>与Canopy Growth一样,Cronos也受益于拥有一个可以加速其在美国烟草巨头增长的合作伙伴<b>奥驰亚</b>2018年向这家大麻公司投资了18亿美元。凭借雄厚的财力和在各州的广泛影响力,奥驰亚可以在合法化后帮助Cronos打入更多市场。</blockquote></p><p>4. Aurora Cannabis</p><p><blockquote>4.极光大麻</blockquote></p><p>Aurora doesn't have a big partner it can lean on, but the company has been making moves to take advantage of opportunities in the U.S. In May 2020, it announced entry into the U.S. market through the acquisition of Reliva, which makes CBD products. The acquisition also brought on board CEO Miguel Martin, who was previously at the helm of Reliva and has 25 years of experience in consumer packaged goods. Reliva's products are in more than 20,000 retail locations and at the time of the acquisition, it claimed to be the \"only CBD company in the three largest U.S. wholesale distributors.\"</p><p><blockquote>Aurora没有可以依靠的大合作伙伴,但该公司一直在采取措施利用美国的机遇。2020年5月,它宣布通过收购生产CBD产品的Reliva进入美国市场。此次收购还聘请了首席执行官米格尔·马丁(Miguel Martin),他曾执掌Reliva,在消费品领域拥有25年的经验。Reliva的产品遍布20,000多个零售点,在收购时,它声称自己是“美国三大批发分销商中唯一的CBD公司”。</blockquote></p><p></p><p>Although Aurora doesn't specifically break out U.S.-related sales, it is safe to assume this transaction, which cost the company approximately $40 million worth of shares (potentially up to $45 million), isn't going to put the company into as promising a position as the other pot stocks on this list. Aurora closed on the transaction in May 2020, but even when including Reliva's results into its operations, it has struggled to generate meaningful growth. In its second-quarter earnings report, released on Feb. 11, its net revenue of 67.7 million Canadian dollars for the period ending Dec. 31, 2020 was flat from the previous period.</p><p><blockquote>尽管Aurora没有具体公布与美国相关的销售情况,但可以肯定的是,这笔交易使该公司损失了价值约4000万美元(可能高达4500万美元)的股票,不会让该公司陷入与该名单上的其他大麻股一样有前途的地位。Aurora于2020年5月完成了交易,但即使将Reliva的业绩纳入其运营中,它也难以实现有意义的增长。在2月11日发布的第二季度收益报告中,截至2020年12月31日的净收入为6770万加元,与上一期持平。</blockquote></p><p>However, investors shouldn't count the company out. Once pot is legal in the U.S., that may open the door for other potential deals for Aurora. Although billionaire investor Nelson Peltz was unable to broker a transaction, more opportunities could arise once the prohibition of marijuana is over and it no longer deters companies in other industries from jumping into the cannabis sector.</p><p><blockquote>然而,投资者不应将该公司排除在外。一旦大麻在美国合法化,这可能会为Aurora的其他潜在交易打开大门。尽管亿万富翁投资者纳尔逊·佩尔茨(Nelson Peltz)无法促成交易,但一旦大麻禁令结束并且不再阻止其他行业的公司进入大麻行业,可能会出现更多机会。</blockquote></p><p>Here's The Marijuana Stock You've Been Waiting For</p><p><blockquote>这是您一直在等待的大麻库存</blockquote></p><p>A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.</p><p><blockquote>一家鲜为人知的加拿大公司刚刚解锁了一些专家认为可能是从即将到来的大麻热潮中获利的关键。</blockquote></p><p>And make no mistake – it is coming.</p><p><blockquote>毫无疑问,它即将到来。</blockquote></p><p>Cannabis legalization is sweeping over North America – 16 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.</p><p><blockquote>大麻合法化正在席卷北美——过去几年,16个州加上华盛顿特区都将娱乐性大麻合法化,加拿大于2018年10月实现了全面合法化。</blockquote></p><p>And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.</p><p><blockquote>一家不为人知的加拿大公司正准备在即将到来的大麻革命中爆发。</blockquote></p><p>Because a game-changing deal just went down between the Ontario government and this powerhouse company...and you need to hear this story today if you have even considered investing in pot stocks.</p><p><blockquote>因为安大略省政府和这家强大的公司刚刚达成了一项改变游戏规则的协议……如果您甚至考虑过投资大麻股票,您今天就需要听听这个故事。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/04/27/4-canadian-cannabis-companies-poised-to-profit-fro/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APHA":"Aphria Inc.","CGC":"Canopy Growth Corporation","CRON":"Cronos Group Inc.","TLRY":"Tilray Inc.","ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/04/27/4-canadian-cannabis-companies-poised-to-profit-fro/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194611822","content_text":"As more and more states legalize marjiuana, federal legalization in the U.S. seems inevitable. Not only are more states passing legislation to permit recreational use, but a vast majority of Americans also support legalization. According to a recent survey, Pew Research found that 91% of people in the U.S. believe marijuana should be legal for either medical or recreational use, with 60% in favor of both. President Joe Biden is in favor of decriminalizing marijuana, while Senate Majority Leader Chuck Schumer is ready to push ahead with full legalization efforts even if Biden isn't completely on board just yet.When legalization happens, there are many Canadian cannabis producers that will be ready to expand their presence south of the border.Canopy Growth(NASDAQ:CGC), soon-to-be-joinedAphria(NASDAQ:APHA)andTilray(NASDAQ:TLRY), Cronos(NASDAQ:CRON), and Aurora Cannabis(NYSE:ACB)could be some of the biggest winners if (or, when) the U.S. pot market opens up.IMAGE SOURCE: GETTY IMAGES.1. Canopy GrowthCanopy Growth has partnerships set up so that it can start working on expansion almost immediately after legalization takes place. One of the first things it would be able to do is close on its acquisition ofAcreage Holdings. Although the two companies came to an agreement in 2019, the transaction is still pending. The multistate operator has a footprint in 13 states with 29 dispensaries that are up and running. In 2020, it reported sales of $114.5 million, which rose 55% year over year. With Acreage Holdings, Canopy Growth would be ready to rival big names likeCuraleafand Trulieveright off the bat.Plus, the company is also working with investorConstellationBrands, which owns nearly 40% of the business, to develop cannabis beverages. Tapping into Constellation's distribution network, Canopy Growth will be poised to grab even more potential market share right out of the gate. And that is why thismarijuana stockis at the top of this list -- it is easily the best positioned cannabis company in Canada to benefit from U.S. legalization.2. Aphria and TilrayThemerger between Aphria and Tilrayputs these two companies next on this list as together, they will have the next-best opportunities in the U.S. In November, Aphria announced the acquisition of SweetWater Brewing. And although the craft brewer does have the 420 brand, which suggests that it makes cannabis drinks, it actually uses hemp (which is legal in the U.S.) toemulatepopular cannabis strains. Legalization would pave the way for the real deal. Tilray has partnered withAnheuser-Busch Inbevsince 2018 on developing drinks for the Canadian pot market, and it will also have beverages that are ready to go.Tilray has also been building out its position in other ways. Hemp plays a big part in its business, generating more than one-third of its revenue in 2020. In 2019, Tilray acquired Manitoba Harvest, a leading hemp business with products that are sold in thousands of retailers across the U.S. and Canada. Through its hemp operations, Tilray can leverage the existing relationships it has with retailers to potentially sell other cannabis products to them post-legalization.3. CronosCronos acquired cannabidiol (CBD) brand Lord Jones in 2019 from Redwood Holding Group. The company sells a variety of CBD-infused products, including oils and gummies. Last year, sales from the U.S. totaled $9.5 million and accounted for just 20% of its consolidated net revenue. But Cronos is definitely looking to change that. Earlier this year it partnered with actress Kristen Bell to launch a series of CBD products under its Happy Dance brand, which will be available at more than 550Ulta Beautylocations.Like Canopy Growth, Cronos also benefits from having a partner that can accelerate its growth in the U.S. Tobacco giantAltriainvested $1.8 billion into the cannabis company in 2018. With deep pockets and wide reach across the states, Altria can help Cronos break into more markets after legalization.4. Aurora CannabisAurora doesn't have a big partner it can lean on, but the company has been making moves to take advantage of opportunities in the U.S. In May 2020, it announced entry into the U.S. market through the acquisition of Reliva, which makes CBD products. The acquisition also brought on board CEO Miguel Martin, who was previously at the helm of Reliva and has 25 years of experience in consumer packaged goods. Reliva's products are in more than 20,000 retail locations and at the time of the acquisition, it claimed to be the \"only CBD company in the three largest U.S. wholesale distributors.\"Although Aurora doesn't specifically break out U.S.-related sales, it is safe to assume this transaction, which cost the company approximately $40 million worth of shares (potentially up to $45 million), isn't going to put the company into as promising a position as the other pot stocks on this list. Aurora closed on the transaction in May 2020, but even when including Reliva's results into its operations, it has struggled to generate meaningful growth. In its second-quarter earnings report, released on Feb. 11, its net revenue of 67.7 million Canadian dollars for the period ending Dec. 31, 2020 was flat from the previous period.However, investors shouldn't count the company out. Once pot is legal in the U.S., that may open the door for other potential deals for Aurora. Although billionaire investor Nelson Peltz was unable to broker a transaction, more opportunities could arise once the prohibition of marijuana is over and it no longer deters companies in other industries from jumping into the cannabis sector.Here's The Marijuana Stock You've Been Waiting ForA little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.And make no mistake – it is coming.Cannabis legalization is sweeping over North America – 16 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.Because a game-changing deal just went down between the Ontario government and this powerhouse company...and you need to hear this story today if you have even considered investing in pot stocks.","news_type":1,"symbols_score_info":{"ACB":0.9,"APHA":0.9,"CGC":0.9,"TLRY":0.9,"CRON":0.9}},"isVote":1,"tweetType":1,"viewCount":1419,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/377715517"}
精彩评论